Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.36 USD | +0.63% | -0.18% | +18.53% |
17/04 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
09/04 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
Sales 2024 * | 535M 44.59B | Sales 2025 * | 576M 48B | Capitalization | 1.37B 114B |
---|---|---|---|---|---|
Net income 2024 * | 22M 1.83B | Net income 2025 * | 34M 2.84B | EV / Sales 2024 * | 2.41 x |
Net cash position 2024 * | 80.28M 6.7B | Net cash position 2025 * | 188M 15.66B | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
50.8
x | P/E ratio 2025 * |
31.8
x | Employees | 642 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.64% |
Latest transcript on ANI Pharmaceuticals, Inc.
1 day | +0.63% | ||
1 week | -0.18% | ||
Current month | -5.45% | ||
1 month | -5.45% | ||
3 months | +19.62% | ||
6 months | +11.01% | ||
Current year | +18.53% |
Managers | Title | Age | Since |
---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 08/20/08 |
Stephen Carey
DFI | Director of Finance/CFO | 53 | 06/16/06 |
Patrick Walsh
CHM | Chairman | 63 | 17/18/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Haughey
BRD | Director/Board Member | 60 | 01/18/01 |
Antonio Pera
BRD | Director/Board Member | 66 | 06/20/06 |
David Nash
BRD | Director/Board Member | 68 | 01/18/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 65.36 | +0.63% | 67,172 |
25/24/25 | 64.95 | -0.73% | 82,931 |
24/24/24 | 65.43 | -1.07% | 83,439 |
23/24/23 | 66.14 | +0.79% | 85,940 |
22/24/22 | 65.62 | +0.21% | 95,322 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.53% | 1.37B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ANIP Stock